🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This important study by Dr. Chen and his laboratory showed that Kmt2c/d functional loss leads to a molecular 'field effect' to prime histologically normal urothelium for oncogenic transformation. Memorial Sloan Kettering Cancer Center MSK Department of Medicine tinyurl.com/5dsuzcbp

The MSK GU Service recently celebrated the illustrious career of Dr. Dean Bajorin. We will miss his wisdom, insight, humor, mentorship, and leadership, but look forward to his continued input as an Emeritus Member at MSK (w/guest star Dr. Bosl).

Please join BCAN in congratulating the recipients of our 2024 Career Development Award, Lay Teng Ang of Stanford University and Brendan Guercio of @wilmotcancer. Both Drs. Ang and Guercio presented outstanding proposals that you can learn more about here: bcan.org/bcan-announces…

STRIKE activated; download docs today! Alliance for Clinical Trials in Oncology National Cancer Institute Can we prevent more recurrences with addition of 6 months of Tivozanib to 1 year of pembrolizumab in patients with resected high risk ccRCC? Dan George Jonathan Rosenberg MD Matt Galsky Toni Choueiri, MD

New Trial Alert! .Bradley McGregor Dana-Farber leads Alliance for Clinical Trials in Oncology A032201 (STRIKE) to compare the effect of adding tivozanib to standard therapy pembrolizumab vs pembrolizumab alone to treat pts w/high-risk renal cell cancer: bit.ly/Alliance-A0322… #NCI #NCTN #RCCsm #CancerResearch

Congratulations Brendan!

Gopa Iyer with first look at LOXO435 - nice activity for FGFR3 inhibition and low AE rate. Our patients UTSW Simmons Cancer Center benefited from this trial! ASCO #GU25

This morning at ASCO #GU25, Robert Motzer MD will share follow-up results from a study that evaluated nivolumab plus cabozantinib vs. sunitinib in people with previously untreated advanced #renalcellcarcinoma. Memorial Sloan Kettering Cancer Center Jonathan Rosenberg MD ➡️buff.ly/3Qg9cQv 8:25 a.m. PST

I am moved by the passion and expertise of the remarkable team at the Olayan Center for Cancer Vaccines (Olayan CCV) and was excited to celebrate their continued work at the Olayan CCV Open House. The standing room-only event brought together Memorial Sloan Kettering Cancer Center cancer vaccine

I am pleased to share that Memorial Sloan Kettering Cancer Center’s state-of-the-art cancer care  pavilion currently under construction will be named The Kenneth C. Griffin Pavilion at Memorial Sloan Kettering Cancer Center. We are deeply grateful to Ken for his extraordinary generosity and all he

On to the keynote lecture by Michael Morris from Memorial Sloan Kettering Cancer Center #TransatlanticExchange Fascinating to see how radioligands can improve survival AND HRQoL… Yet so much remains to be done and improved!

Dr Hikmat Al-Ahmadie highlights markers in #urothelialcarcinoma which may be therapeutically targeted including MMRd/MSI, FGFR3, and antibody-drug conjugate (ADC) markers such as NECTIN-4 and HER2 #gupath GU Pathology Society (GUPS) #USCAP2025

Join us for the AUA-IBCG Bladder Cancer Forum April 28, 2–5 pm 🗓️ #AUA25 Amer. Urol. Assn. IBCG Kelly Bree Petros Grivas Laura Bukavina Shilpa Gupta Neha Vapiwala Wes Kassouf Peter Black Patrick Hensley, MD Hikmat Al Ahmadie Joshua Meeks Benjamin Pradere Sia Daneshmand, M.D. Vignesh Packiam, MD

I am very privileged to work with Bernie Bochner, MD on a daily basis. This is a truly well deserved recognition.

#PREDICT trial investigates biomarker-guided treatment for advanced #ProstateCancer. Rana McKay, MD, FASCO UC San Diego and Alicia Morgans, MD, MPH Dana-Farber to discuss the PREDICT trial — a biomarker-driven approach for mCRPC patients post-ARPI. 💡 DNA and RNA profiling 🔍 Targeted arms:

Excited for tomorrow! #AACR2025

Insightful talk by Maria J. Ribal on perioperative management on MIBC with balance of pros/cons, rationale, data! Several P2 trials & NIAGARA reported, awaiting KN866, GC +/- Nivo & EV-IO trials! #ASCO25 OncoAlert ASCO Shilpa Gupta Jonathan Rosenberg MD Ali Khaki Vadim Koshkin MD Dr. Bishoy M. Faltas

Fantastic presentation by Jonathan Rosenberg MD @asco #ASCO25

Congrats to our stellar medical student Alyssa Arbuisa on her abstract evaluating cutaneous rash with I/O response. #ASCO2025 Memorial Sloan Kettering Cancer Center

Awesome poster from Michal Sternschuss on platinum-based chemotherapy after EV + pembro in metastatic urothelial carcinoma! Jonathan Rosenberg MD Memorial Sloan Kettering Cancer Center MSK Department of Medicine ASCO #ASCO25